Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Upregulation of CYP1B1 expression by inflammatory cytokines is mediated by the p38 MAP kinase signal transduction pathway

L. Smerdová, J. Svobodová, M. Kabátková, J. Kohoutek, D. Blažek, M. Machala, J. Vondráček,

. 2014 ; 35 (11) : 2534-2543.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc15014069

Grant support
NT14599 MZ0 CEP Register

Cytochrome P450 1B1 (CYP1B1) is an enzyme that has a unique tumor-specific pattern of expression and is capable of bioactivating a wide range of carcinogenic compounds. We have reported previously that coordinated upregulation of CYP1B1 by inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and the aryl hydrocarbon receptor ligands, may increase bioactivation of promutagens, such as benzo[a]pyrene (BaP) in epithelial cells. Here, we extend those studies by describing a novel mechanism participating in the regulation of CYP1B1 expression, which involves activation of the p38 mitogen-activated protein kinase (p38) and mitogen- and stress-activated protein kinase 1 (MSK1). Using inhibitors of p38 and MSKs, as well as mouse embryonic cells derived from p38α-deficient and MSK1/2 double knockout mice, we show here that TNF-α potentiates CYP1B1 upregulation via the p38/MSK1 kinase cascade. Effects of this inflammatory cytokine on CYP1B1 expression further involve the positive transcription elongation factor b (P-TEFb). The inhibition of the P-TEFb subunit, cyclin-dependent kinase 9 (CDK9), which phosphorylates RNA polymerase II (RNAPII), prevented the enhanced CYP1B1 induction by a combination of BaP and inflammatory cytokine. Furthermore, using chromatin immunoprecipitation assays, we found that cotreatment of epithelial cells with TNF-α and BaP resulted in enhanced recruitment of both CDK9 and RNAPII to the Cyp1b1 gene promoter. Overall, these results have implications concerning the contribution of inflammatory factors to carcinogenesis, since enhanced CYP1B1 induction during inflammation may alter metabolism of exogenous carcinogens, as well as endogenous CYP1B1 substrates playing role in tumor development.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014069
003      
CZ-PrNML
005      
20191022102114.0
007      
ta
008      
150420s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/carcin/bgu190 $2 doi
035    __
$a (PubMed)25233930
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Smerdová, Lenka $u Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno 62165, Czech Republic.
245    10
$a Upregulation of CYP1B1 expression by inflammatory cytokines is mediated by the p38 MAP kinase signal transduction pathway / $c L. Smerdová, J. Svobodová, M. Kabátková, J. Kohoutek, D. Blažek, M. Machala, J. Vondráček,
520    9_
$a Cytochrome P450 1B1 (CYP1B1) is an enzyme that has a unique tumor-specific pattern of expression and is capable of bioactivating a wide range of carcinogenic compounds. We have reported previously that coordinated upregulation of CYP1B1 by inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and the aryl hydrocarbon receptor ligands, may increase bioactivation of promutagens, such as benzo[a]pyrene (BaP) in epithelial cells. Here, we extend those studies by describing a novel mechanism participating in the regulation of CYP1B1 expression, which involves activation of the p38 mitogen-activated protein kinase (p38) and mitogen- and stress-activated protein kinase 1 (MSK1). Using inhibitors of p38 and MSKs, as well as mouse embryonic cells derived from p38α-deficient and MSK1/2 double knockout mice, we show here that TNF-α potentiates CYP1B1 upregulation via the p38/MSK1 kinase cascade. Effects of this inflammatory cytokine on CYP1B1 expression further involve the positive transcription elongation factor b (P-TEFb). The inhibition of the P-TEFb subunit, cyclin-dependent kinase 9 (CDK9), which phosphorylates RNA polymerase II (RNAPII), prevented the enhanced CYP1B1 induction by a combination of BaP and inflammatory cytokine. Furthermore, using chromatin immunoprecipitation assays, we found that cotreatment of epithelial cells with TNF-α and BaP resulted in enhanced recruitment of both CDK9 and RNAPII to the Cyp1b1 gene promoter. Overall, these results have implications concerning the contribution of inflammatory factors to carcinogenesis, since enhanced CYP1B1 induction during inflammation may alter metabolism of exogenous carcinogens, as well as endogenous CYP1B1 substrates playing role in tumor development.
650    _2
$a zvířata $7 D000818
650    _2
$a karcinogeneze $x účinky léků $x genetika $7 D063646
650    _2
$a karcinogeny $x toxicita $7 D002273
650    _2
$a cyklin-dependentní kinasa 9 $x genetika $7 D042863
650    _2
$a cytochrom P450 CYP1B1 $x biosyntéza $x genetika $7 D065633
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a regulace genové exprese u nádorů $x účinky léků $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a nádory $x chemicky indukované $x genetika $x patologie $7 D009369
650    _2
$a pozitivní transkripční elongační faktor b $x genetika $7 D042925
650    _2
$a RNA-polymerasa II $x genetika $7 D012319
650    _2
$a signální transdukce $x účinky léků $7 D015398
650    _2
$a TNF-alfa $x metabolismus $7 D014409
650    _2
$a mitogenem aktivované proteinkinasy p38 $x antagonisté a inhibitory $x genetika $x metabolismus $7 D048051
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Svobodová, Jana $u Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno 62165, Czech Republic, Institute of Experimental Biology, Faculty of Science, Brno 61137, Czech Republic.
700    1_
$a Kabátková, Markéta $u Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno 62165, Czech Republic, Institute of Experimental Biology, Faculty of Science, Brno 61137, Czech Republic.
700    1_
$a Kohoutek, Jiří $u Department of Chemistry and Toxicology, Veterinary Research Institute, Brno 62100, Czech Republic and. $7 xx0081824
700    1_
$a Blažek, Dalibor $u Central European Institute of Technology (CEITEC), Masaryk University, Brno 62500, Czech Republic. $7 xx0185888
700    1_
$a Machala, Miroslav $u Department of Chemistry and Toxicology, Veterinary Research Institute, Brno 62100, Czech Republic $7 xx0094277
700    1_
$a Vondráček, Jan, $u Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno 62165, Czech Republic, vondracek@ibp.cz. $d 1970- $7 xx0137878
773    0_
$w MED00001050 $t Carcinogenesis $x 1460-2180 $g Roč. 35, č. 11 (2014), s. 2534-2543
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25233930 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20191022102548 $b ABA008
999    __
$a ok $b bmc $g 1071650 $s 896947
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 35 $c 11 $d 2534-2543 $i 1460-2180 $m Carcinogenesis $n Carcinogenesis $x MED00001050
GRA    __
$a NT14599 $p MZ0
LZP    __
$a Pubmed-20150420

Find record

Citation metrics

Archiving options